Oramed Pharmaceuticals Inc. (ORMP)

Oramed Pharmaceuticals Revenue

Oramed Pharmaceuticals had revenue of $2.00M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $2.00M, up 196.74% year-over-year.

• Revenue (ttm): $2.00M
• Revenue Growth: +196.74%
• P/S Ratio: 45.43
• Revenue / Employee: $153,846
• Employees: 13
• Market Cap: 90.69M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	1.34M	-1.36M	-50.43%
Dec 31, 2022	2.70M	-9.00K	-0.33%
Dec 31, 2021	2.71M	9.00K	0.33%
Aug 31, 2021	2.70M	-9.00K	-0.33%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.